Skip to main content
. 2015 Jun 12;10:951–961. doi: 10.2147/CIA.S69278

Table 7.

CLL11 serious adverse events (grade 3 or greater)

Obinutuzumab/chlorambucil Rituximab/chlorambucil Chlorambucil
Any event (%) 70 55 50
Infusion reactions (%) 20 4 0
Neutropenia (%) 33 28 16
Anemia (%) 4 4 4
Thrombocytopenia (%) 10 3 4
Leukopenia (%) 4 1 0
Infections (%) 12 14 14
Pneumonia (%) 4 5 3
Febrile neutropenia (%) 2 1 4

Note: Data from Goede et al.45

Abbreviation: CLL, chronic lymphocytic leukemia.